Hologic expands Acclaim DEXA series

Article

Bone densitometry firm Hologic will showcase the expansion ofits QDR-4500 Acclaim line of dual-energy x-ray absorptiometryscanners, which debuted at last year's RSNA meeting with the introductionof the QDR-4500A system. Hologic, of Waltham, MA, has added

Bone densitometry firm Hologic will showcase the expansion ofits QDR-4500 Acclaim line of dual-energy x-ray absorptiometryscanners, which debuted at last year's RSNA meeting with the introductionof the QDR-4500A system.

Hologic, of Waltham, MA, has added three new DEXA scanners tothe line, to be positioned at price points below the flagshipQDR-4500A. QDR-4500C is for spine and hip scanning, QDR-4500Wis targeted at spine, hip and total body work, and QDR-4500SLis for spine, hip and lateral scanning, according to Joel Weinstein,vice president of business development and marketing. Any of thenew scanners can be upgraded to the QDR-4500A.

Hologic will also show a new ultrasound bone densitometry productcalled Sahara. Sahara is based on technology Hologic acquiredwhen it bought WalkerSonix earlier this year. Sahara differs fromthe WalkerSonix devices and other ultrasound densitometers onthe market in that it does not require a water bath for bone scanning,Weinstein said.

Hologic this month reported strong financial results for its1995 fiscal year due to increased interest in bone densitometry.The company saw revenues increase 13% to $43.4 million while netincome stood at $1.9 million, a drop of 38% caused by legal costsassociated with its patent litigation with Lunar. The financialresults prompted the company's stock to surge 13% on Nov. 8 to$29.75 a share.

Newsletter

Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.

Recent Videos
SNMMI: Emerging PET Insights on Neuroinflammation with Progressive Apraxia of Speech (PAOS) and Parkinson-Plus Syndrome
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
Related Content
© 2025 MJH Life Sciences

All rights reserved.